Association of systemic and ocular risk factors with neurosensory retinal detachment in diabetic macular edema: a case–control study by Aditi Gupta et al.
Gupta et al. BMC Ophthalmology 2014, 14:47
http://www.biomedcentral.com/1471-2415/14/47RESEARCH ARTICLE Open AccessAssociation of systemic and ocular risk factors
with neurosensory retinal detachment in diabetic
macular edema: a case–control study
Aditi Gupta1, Rajiv Raman1, Vaitheeswaran Kulothungan2 and Tarun Sharma1*Abstract
Background: Diabetic macular edema (DME) with neurosensory retinal detachment (NSD) remains an important
cause of visual loss in patients with diabetes. The aim of the study was to elucidate the association of systemic and
ocular risk factors with NSD in DME.
Methods: In a retrospective case–control study, we reviewed clinical records of all the subjects with DME seen
between January 2010 and December 2010. Cases and controls were selected based on optical coherence
tomography and stereoscopic biomicroscopy review. NSD was defined as subfoveal fluid accumulation under
detached retina with or without overlying foveal thickening. The association between the presence of NSD, blood
pressure, lipid status and various other biochemical parameters was evaluated.
Results: Group I (cases) included 37 eyes of 33 patients having DME with NSD and Group II (controls) included 30
eyes of 21 patients having DME without NSD. Patients ranged in age (mean ± SD) from 50 to 62 years (56.6 +/-6.78)
for cases and from 51 to 65 years (58.4+/-7.84) for controls. The duration of diabetes ranged from 4 to 15 year
(mean 9.45+/-6.08) among cases and 4 to 14 years (9.7+/-5.12) among controls. Significant risk factors for NSD were
high values of systolic and diastolic blood pressure (p = 0.039 and 0.043 respectively).
Conclusion: High systolic and diastolic blood pressures are independent and significant risk factors for NSD in DME.
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Diabetic macular edema (DME) remains a major cause
of visual loss in patients with diabetes [1]. Optical coher-
ence tomography (OCT) has specifically been used for
characterizing the morphological features of DME, and
five OCT patterns of DME have been described: diffuse
retinal thickening (DRT), cystoid macular edema (CME),
neurosensory retinal detachment (NSD) without poster-
ior hyaloidal traction, posterior hyaloidal traction (PHT)
without tractional retinal detachment (TRD) and PHT
with TRD [2-5]. NSD under the fovea has been reported
in 3–31% of patients with DME [2,4-10].
The prognosis of DME is decided by many factors, such
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reproduction in any medium, provided the or(IS/OS) conjunction and integrity of the external limit-
ing membrane (ELM) line [11-13]. IS/OS integrity and
intact ELM are important indicators in the evaluation of
foveal photoreceptor layer integrity, and correlate strongly
with best-corrected visual acuity (BCVA) after medical or
surgical treatment of DME [11,12].
The presence of NSD is found to adversely affect the
prognosis of DME. NSD can significantly limit effective
laser treatment of the macula [14]. The presence of NSD
in DME associated with subretinal exudation has been
reported to be associated with poor visual prognosis after
vitrectomy [2]. Likewise, in macular edema secondary to
branch retinal vein occlusion, the presence of subfoveal
NSD was shown to retard the absorption of macular
edema and recovery of vision after grid laser photocoagu-
lation [14]. The high percentage of NSD in CRVO [9] may
have played a role in the poor response of macular edema
to grid laser photocoagulation in the multicenter trial ontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Group [15]. Hence, the need to better understand the
pathogenesis of NSD has been stressed [15]. Although
previous studies have extensively reported the systemic
and ocular risk factors for the presence of DME [16-20],
the risk factors associated with NSD in DME have been
rarely studied in detail [21]. A recent study indicated
the presence of high glycosylated hemoglobin (HbA1c)
as a risk factor for NSD, suggesting the role of systemic
factors in the causation of NSD in DME [21]. The aim
of this study was to elucidate the association of various
systemic and ocular risk factors with NSD in Indian
subjects with DME.
Methods
This study was a retrospective chart review of patients
with diagnosed DME seen between Jan 2010 to Dec 2010.
Cases and controls were selected based on SD-OCT re-
view. Group I (cases) included 37 eyes of 33 patients who
were diagnosed as DME with NSD on OCT and Group II
(controls) included 30 eyes of 21 patients who had DME
without NSD. The macular edema was diagnosed by bio-
microscopy according to the criteria reported by ETDRS.
NSD type DME was defined as subfoveal fluid accumula-
tion with distinct outer border of detached retina with or
without overlying foveal thickening (Figure 1). All cases
had NSD associated with DRT or CME (Figure 1). All
controls had DRT or CME without any NSD (Figure 2).
Patients with posterior hyaloidal traction (PHT) without
TRD and PHT with TRD as documented on OCT, and
media opacities such as corneal opacity, dense cataract,
vitreous or preretinal hemorrhage, uveitis were excluded
from the study. This study was approved by the Institu-
tional Review Board, Vision Research Foundation andFigure 1 Spectral domain OCT shows diffuse retinal thickening (A) an
cystoid macular edema (B) with associated subfoveal neurosensory dadhered to the Declaration of Helsinki. The medical re-
cords of all the patients including cases and controls were
reviewed, with documentation of patients’ age, gender,
duration and type of diabetes mellitus, history of any asso-
ciated systemic disease like hypertension, hyperlipidemia,
nephropathy, ischemic heart disease status post coronary
artery bypass surgery, details of systemic medications, his-
tory of ocular surgeries including intravitreal injections
and laser treatment in the past. The details of patients’
ocular examination findings including BCVA on Snellen
chart (later converted to logMAR for statistical analyses),
lens status, stage of diabetic retinopathy, OCT findings,
and systemic biochemical parameters were also noted. A
prototype SD-OCT system (Topcon 3D1000, Tokyo,
Japan) was used with an axial resolution of 6u and ac-
quisition rate of approximately 18,000 scans per second.
All OCT images were acquired through a dilated pupil.
During the OCT examination, macula was scanned on
six radial sections including the horizontal, vertical and
oblique planes through the centre of the fovea. The ret-
inal thickness was measured as distance of vitreoretinal
interface and inner edge of retinal pigment epithelium
(RPE) at the maximum point of edema. Central subfield
retinal thickness was also noted on OCT.
The blood pressure was recorded, in the sitting position,
in the right arm to the nearest 2 mm Hg using the mer-
cury sphygmomanometer (Diamond Deluxe BP apparatus,
Pune, India). Two readings were taken with a five minutes
interval and their mean indication was taken as the blood
pressure. In most of the subjects, the blood pressure
measurement was taken on the day of complete ophthal-
mic examination which included OCT. In the remaining
subjects, blood pressure was measured on the day of OCT
review which was 1 or 2 days later. The biochemicald hyporeflective cystic spaces in the inner retina suggestive of
etachment.
Figure 2 Spectral domain OCT shows diffuse retinal thickening (A) and hyporeflective cystic spaces in the inner retina suggestive of
cystoid macular edema (B) without any neurosensory detachment.
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sugar levels, hemoglobin, glycosylated hemoglobin, blood
pressure and renal function tests (serum urea and serum
creatinine). All biochemical parameters were done at same
laboratory using standard techniques. The grading of
diabetic retinopathy was done based on modified klein
classification as mild, moderate and severe nonproli-
ferative diabetic retinopathy and proliferative diabetic
retinopathy [22]. The modification was proposed as a
standardized alternative to the more detailed Early Treat-
ment Diabetic Retinopathy Study (ETDRS) system. It in-
volves grading seven stereoscopic standard fields as a
whole, and assigning a level of severity for the eye accord-
ing to the greatest degree of retinopathy using a modified
Airlie House Classification scheme [22].
Statistical analysis
A computerized database was created for all the records.
Statistical analyses were performed using SPSS Windows
version 14.0 (SPSS Science, Chicago, IL, USA). All the
data were expressed as mean ± S.D or as percentage.
The normality of distribution was checked for all factors
by Kolmogorov–Smirnov analysis. The data in the study
followed normal distribution, hence we used the para-
metric tests to determine significance. Chi-square test
was used to compare proportions among neurosensory
detachment status with the independent categorical vari-
ables and the Student’s t-test was used to compareproportions among neurosensory detachment status with
the independent measured (continuous) variables in Uni-
variate analyses. P value less than 0.05 was considered sig-
nificant. Multivariate analyses could not be done because
of small sample size in both the groups.Results
A total of 37 eyes of 33 patients who had NSD with DME
(Group 1, cases) and 30 eyes of 21 patients who had DME
without NSD (Group 2, controls) were included in our
study. All patients included were of type 2 diabetes melli-
tus. The patients ranged in age from 50 to 62 years among
the cases (mean 56.6 +/-6.7) and 51 to 65 among the con-
trols (mean 58.4+/7.84). The duration of diabetes ranged
from 4 to 15 years (mean 9.45+/-6.08) among cases and 4
to 14 years (9.7+/-5.12) among controls. Group 1 included
28 males (84.8%) and 5 females (15.2%) and Group 2 in-
cluded 14 males (67.7%) and 7 females (33.3%).
Table 1 depicts the comparison of systemic factors as-
sociated with cases and controls. There were no signifi-
cant differences in the two groups in terms of the mean
age (p = 0.375), duration of diabetes (p = 0.876), fasting
blood sugar and post prandial blood sugar levels (p =
0.959 and 0.436 respectively), glycosylated hemoglobin
(p = 0.859), hemoglobin (p = 0.118) and presence of hyper-
tension (p = 0.634). However, the mean systolic and dia-
stolic blood pressures were significantly higher (p = 0.039







Age (years) 56.6+/-6,78 58.4 +/-7.84 0.375
Gender n (%)
Males 28 (84.8%) 14 (66.7%)
Females 5 (15.2%) 7 (33.3%)
Duration of diabetes
(years)
9.45 +/- 6.08 9.7 +/-5.12 0.876
Systemic
associations n (%)
Hypertension 24 (72.7%) 14 (66.7%) 0.634
Hyperlipidemia 3 (9.1%) 1 (4.8%) 1.000
Nephropathy 1 (3%) 0 1.000
S/p CABG 1 (3%) 0 1.000
Systemic
medications n (%)
Antidiabetic insulin 3 (9.1%) 3 (14.3%) 0.667
Group 1 (biguanides) 7 (21.2%) 9 (42.9%) 0.089
Group 2 (glitazones) 5 (15.2%) 1 (4.8%) 0.386
Group 3 (sulfonylureas) 22 (66.7%) 14 (66.7%) 1.000
Antihypertensive 18 (54.6%) 10 (47.6%) 0.619
Mean value of
systemic parameters
HbA 1c 6.73 +/- 1.42 6.71 +/- 1.39 0.859
SBP (mm Hg) 147.84 +/- 11.33 141 +/- 11.88 0.039
DBP (mm Hg) 85.24 +/-5.98 81.47 +/- 7.29 0.043
FBS (mg%) 144.05 +/- 81.59 142.94 +/- 70.42 0.959
PPBS (mg%) 229.17 +/- 112.52 208.15 +/- 60.97 0.436
Urea 37.82 +/- 17.0 34.52 +/- 19.0 0.509
Creatinine 1.41 +/- 0.74 1.07 +/- 0.331 0.053
Hemoglobin (g%) 10.71 +/- 2.36 11.77 +/- 2.44 0.118
S/P CABG: Status post coronary artery bypass graft, HbA1c: Glycosylated
hemoglobin, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, FBS:
fdasting blood sugar, PPBS: Post prandial blood sugar.
P value <0.05 considered significant (boldface).









0.822 +/- 0.421 0.61+/- 0.470 0.056
Mean CMT
(microns)
485.7 +/- 189.81 332.2 +/- 134.14 0.0004
Type of
edema n (%)
CME 25 (67.6%) 14 (46.7%) 0.085
Diffuse 12 (32.4%) 16 (53.3%)
Stage of
DR n (%)
Mild NPDR 0 6 (20%) 0.820
Moderate NPDR 15 (40.5%) 15 (50%)
Severe NPDR 9 (24.3%) 2 (6.7%)
PDR 13 (35.1%) 7 (23.3%)
Phakic status
n (%)
Phakic 33 (89.2%) 29 (96.7%) 0.370
Aphakic 0 0




19 (51.4%) 6 (20%) 0.008
S/P PRP n (%) 12 (32.4%) 6 (20%) 0.254
Bcva: Best corrected visual acuity, CMT: Central macular thickness, CME:
Cystoid macular edema, DR: Diabetic retinopathy, NPDR: Non proliferative DR,
VEGF: Vascular endothelial growth factor, S/P PRP: status post pan
retinal therapy.
P value <0.05 considered significant (boldface).
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group.
Table 2 compares the ocular factors among eyes with
NSD and control eyes. The mean log MAR BCVA was
0.822 +/-0.421 in NSD group and 0.61+/-0.47 in the con-
trol group (p 0.056). The mean central macular thickness
as determined by OCT was higher in cases than in the
controls (485.7 +/-189.81 versus 332.2+/-134.14 microns,
p = 0.0004). Cystoid macular edema was more commonly
seen than diffuse edema in NSD group, although the dif-
ference was not significant (p = 0.085). 35.1% of eyes with
NSD had associated proliferative diabetic retinopathy
compared to 23.3% in the control group (p = 0.820). There
were no significant differences in the two groups in termsof pseudophakic status (p = 0.370). As expected, ocular
surgery including anti- VEGF injections were performed
more frequently in Group 1 (p = 0.008).
Discussion
DME remains the leading cause of visual loss among pa-
tients with diabetes mellitus. Among the various patterns
of DME, NSD under the fovea has been reported in 3–
31% of patients. The pathogenesis of NSD is linked not
only to the limitations of the draining vascular system, but
also to impairment in the function of the RPE. Kang et al.
reported that in diabetic eyes, the incidence of CME and
NSD increasd with the existence of retinal vascular hyper-
permeability and the pathology of these two phenomena
might share a common pathogenesis in this regard [4].
Various systemic factors have been associated with in-
creased incidence of DME like severity of diabetic retin-
opathy, poor glycemic control and duration of diabetes.
Hypertension, proteinuria, dyslipidemia, uncontrolled renal
parameters, and PRP for PDR (causing acute choroidal
ischemia), have also been associated with increased risk of
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with increased incidence of DME, very few studies have
correlated the presence of uncontrolled systemic disease
and biochemical parameters with increased incidence of
NSD in DME. Poor control of systemic factors could be
related to increased leakage from the capillaries with loss
of vascular integrity as well to an impaired function of
RPE. One study demonstrated the presence of high
HbA1c levels in the patients with diabetic CME and NSD,
compared to those with diabetic CME and no associated
NSD [21]. In our study, we did not find a significant asso-
ciation between HbA1c and presence of NSD. Instead,
only high mean systolic and diastolic blood pressures were
found to be independent and significant risk factors for
NSD in DME.
Increased blood pressure has been implicated, through
the effects of increased blood flow, to cause damage to
the retinal capillary endothelial cells in eyes of diabetic
patients [23]. Elevated blood pressure also alters the ret-
inal arteriolar hemodynamics, causing a reduction in the
compliance (i.e., an increase of vascular rigidity) of the
arteriolar circulation with increasing risk of DME [20].
Hypertension is a well recognized cause of NSD preferen-
tially affecting the macular region, although NSD is more
commonly accompanied with malignant hypertension
[24,25]. The occurrence of NSD in DME can be secondary
to excessive leakage in retina or to a poorly functioning
RPE. Raised blood pressure can lead to increased retinal
leakage as well as ischemic damage to RPE. Another possi-
bility is that diabetes may have caused subclinical chor-
oidal vascular damage in diabetic subjects, rendering the
circulatory system more susceptible to further ischemic
insult by raised blood pressure.
Choroidal vascular damage causes ischemic damage to
the RPE and leads to breakdown of the blood-retinal
barrier with transudation of fluid into subretinal space.
Hayreh observed that the presence of NSD was corre-
lated to the degree of choroidal circulation disruption.
Fluid overload has also been implicated as a cause of
NSD [26].
Anemia is another known risk factor for DME. Low
hemoglobin levels can occur in diabetic patients secondary
to renal disease or can occur independently. However, the
renal disease as measured by serum urea and creatinine
was not found to be associated with NSD in this study.
Futhermore, anemia was not found as an independent risk
factor for formation of NSD. Low hemoglobin has been
described as an independent baseline risk factor in the
EDTRS for the development of DME and severe visual
loss [27]. Other studies have corroborated this finding [18]
and have also found improvement in the DME status fol-
lowing correction of anemia [28-30]. Correction of anemia
(and also supplementation of erythropoietin) was noted
to decrease the effects of retinopathy with structuralimprovement, possibly through improved oxygenation
of the macula [28]. Singh et al. noted spontaneous clos-
ure of microaneurysms in diabetic retinopathy with
treatment of co-existing anemia [30]. Friedman et al. re-
ported that increased hematocrit may improve visual
acuity due to resolution of macular edema in diabetic
retinopathy [29]. Over the past few years, growing evi-
dence supports the hypothesis that hypoxia contributes
to progression of tissue injury in diabetic individuals
[31]. In our study, although the patients with NSD had
lower hemoglobin, none of them had significantly low
hemoglobin levels which could be clinically called as
anemia. This could be the reason why we were unable
to find any significant effect of anemia on NSD.
Conclusion
In conclusion, we found high systolic and diastolic blood
pressures to be independent and significant risk factors
for NSD in DME. The present study suggests that the
treating ophthalmologists should get a complete systemic
workup done for the presence of co-morbidities especially
high blood pressure in subjects with NSD in DME.
Achieving adequate metabolic control of associated condi-
tions should be aimed in such subjects. Prospective studies
are warranted to see whether decreasing the blood
pressure of the patient will help in the resolution of
NSD in DME.
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